2020
DOI: 10.1016/j.bone.2020.115370
|View full text |Cite
|
Sign up to set email alerts
|

Disruption of the aldehyde dehydrogenase 2 gene increases the bone anabolic response to intermittent PTH treatment in an ovariectomized mouse model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 51 publications
0
2
0
Order By: Relevance
“…Mice were given low-(20 μg/kg) or high-(40 μg/kg) concentration recombinant human PTH; the mice were categorized into the low-concentration PTH (LPTH) group and the high-concentration PTH (HPTH) group, respectively. During the modelling, PTH was injected into the mice by subcutaneous injection at 10 : 00 daily [20].…”
Section: 2mentioning
confidence: 99%
“…Mice were given low-(20 μg/kg) or high-(40 μg/kg) concentration recombinant human PTH; the mice were categorized into the low-concentration PTH (LPTH) group and the high-concentration PTH (HPTH) group, respectively. During the modelling, PTH was injected into the mice by subcutaneous injection at 10 : 00 daily [20].…”
Section: 2mentioning
confidence: 99%
“…The single nucleotide polymorphism of aldehyde dehydrogenase 2 (ALDH2) at rs671 loci correlates with osteoporosis development and osteoporotic hip fracture [ 35 ]. Mice lacking the Aldh2 gene show high bone mass phenotypes and increased responses to the bone anabolic actions of PTH treatment [ 36 ].…”
Section: The Role Of Mitochondrial Homeostasis In Bone-forming Cell Functionmentioning
confidence: 99%